​
​

Eiger BioPharmaceuticals (EIGR) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

Eiger BioPharmaceuticals Revenue Highlights

Latest Revenue (Y)

$15.77M

Latest Revenue (Q)

$3.80M

Main Segment (Y)

Product

Eiger BioPharmaceuticals Revenue by Period

Eiger BioPharmaceuticals Revenue by Year

DateRevenueChange
2023-12-31$15.77M16.98%
2022-12-31$13.48M11.05%
2021-12-31$12.14M100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31-100.00%
2011-06-30--

Eiger BioPharmaceuticals generated $15.77M in revenue during NA 2023, up 16.98% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Eiger BioPharmaceuticals Revenue by Quarter

DateRevenueChange
2023-12-31$3.80M18.51%
2023-09-30$3.21M-30.89%
2023-06-30$4.64M12.75%
2023-03-31$4.12M52.74%
2022-12-31$2.70M-33.00%
2022-09-30$4.02M-1.64%
2022-06-30$4.09M53.05%
2022-03-31$2.67M-20.45%
2021-12-31$3.36M10.56%
2021-09-30$3.04M44.92%
2021-06-30$2.10M-42.48%
2021-03-31$3.65M100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31-100.00%
2012-12-31-100.00%
2012-09-30--

Eiger BioPharmaceuticals generated $3.80M in revenue during Q4 2023, up 18.51% compared to the previous quarter, and up 94.51% compared to the same period a year ago.

Eiger BioPharmaceuticals Revenue Breakdown

Eiger BioPharmaceuticals Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 22
Product$12.73M
Other Revenue$750.00K

Eiger BioPharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 22: Product (94.44%), and Other Revenue (5.56%).

Quarterly Revenue by Product

Product/ServiceJun 23Mar 23Dec 22Sep 22Jun 22
Other Revenue$250.00K--$750.00K-
Product$4.39M$4.12M$2.70M$4.02M$3.34M

Eiger BioPharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Jun 23: Product (94.62%), and Other Revenue (5.38%).

Eiger BioPharmaceuticals Revenue Breakdown by Country

Quarterly Revenue by Country

CountryMar 23Dec 22Sep 22Jun 22
Product$4.12M$2.70M$4.02M$3.34M
Other Revenue---$750.00K

Eiger BioPharmaceuticals's latest quarterly revenue breakdown by geography, as of Mar 23: Product (100.00%).

Eiger BioPharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CHRSCoherus BioSciences$257.24M$70.77M
SPROSpero Therapeutics$96.73M$13.47M
ETONEton Pharmaceuticals$31.64M$10.32M
HOWLWerewolf Therapeutics$19.94M$1.14M
EIGREiger BioPharmaceuticals$15.77M$3.80M
SPRBSpruce Biosciences$10.09M$1.61M
APLTApplied Therapeutics$9.99M$144.00K
BOLTBolt Biotherapeutics$7.88M$1.14M
FUSNFusion Pharmaceuticals$2.07M-
LYRALyra Therapeutics$1.56M$195.00K
UNCYUnicycive Therapeutics$675.00K-
FNCHFinch Therapeutics Group$107.00K-
XFORX4 Pharmaceuticals-$560.00K
GRCLGracell Bio--
DAWNDay One Biopharmaceuticals-$20.07M
CNTBConnect Biopharma--
CINGCingulate--
ABOSAcumen Pharmaceuticals--
INZYInozyme Pharma--
NLTXNeurogene--
TERNTerns Pharmaceuticals--
NUVBNuvation Bio-$727.00K
ELDNEledon Pharmaceuticals--

EIGR Revenue FAQ

What is Eiger BioPharmaceuticals’s yearly revenue?

Eiger BioPharmaceuticals's yearly revenue for 2023 was $15.77M, representing an increase of 16.98% compared to 2022. The company's yearly revenue for 2022 was $13.48M, representing an increase of 11.05% compared to 2021. EIGR's yearly revenue for 2021 was $12.14M, representing an increase of 100.00% compared to 2020.

What is Eiger BioPharmaceuticals’s quarterly revenue?

Eiger BioPharmaceuticals's quarterly revenue for Q4 2023 was $3.8M, a 18.51% increase from the previous quarter (Q3 2023), and a 41.06% increase year-over-year (Q4 2022). The company's quarterly revenue for Q3 2023 was $3.21M, a -30.89% decrease from the previous quarter (Q2 2023), and a -20.25% decrease year-over-year (Q3 2022). EIGR's quarterly revenue for Q2 2023 was $4.64M, a 12.75% increase from the previous quarter (Q1 2023), and a 13.49% increase year-over-year (Q2 2022).

What is Eiger BioPharmaceuticals’s revenue growth rate?

Eiger BioPharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 29.90%, and for the last 5 years (2019-2023) was 0%.

What are Eiger BioPharmaceuticals’s revenue streams?

Eiger BioPharmaceuticals's revenue streams in c 22 are Product, and Other Revenue. Product generated $12.73M in revenue, accounting 94.44% of the company's total revenue Other Revenue generated $750K in revenue, accounting 5.56% of the company's total revenue

What is Eiger BioPharmaceuticals’s main source of revenue?

For the fiscal year ending Dec 22, the largest source of revenue of Eiger BioPharmaceuticals was Product. This segment made a revenue of $12.73M, representing 94.44% of the company's total revenue.